268 related articles for article (PubMed ID: 30630325)
21. Fecal Microbiota Transplantation in Inflammatory Bowel Disease.
Reinisch W
Dig Dis; 2017; 35(1-2):123-126. PubMed ID: 28147375
[TBL] [Abstract][Full Text] [Related]
22. The gut microbiota and inflammatory bowel disease.
Matsuoka K; Kanai T
Semin Immunopathol; 2015 Jan; 37(1):47-55. PubMed ID: 25420450
[TBL] [Abstract][Full Text] [Related]
23. Specific changes of enteric mycobiota and virome in inflammatory bowel disease.
Chu Y; Jiang MZ; Xu B; Wang WJ; Chen D; Li XW; Zhang YJ; Liang J
J Dig Dis; 2018 Jan; 19(1):2-7. PubMed ID: 29266753
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome.
Celiberto LS; Graef FA; Healey GR; Bosman ES; Jacobson K; Sly LM; Vallance BA
Immunology; 2018 Sep; 155(1):36-52. PubMed ID: 29693729
[TBL] [Abstract][Full Text] [Related]
25. Role of exercise in preventing and restoring gut dysbiosis in patients with inflammatory bowel diseases: A review.
Koutouratsas T; Philippou A; Kolios G; Koutsilieris M; Gazouli M
World J Gastroenterol; 2021 Aug; 27(30):5037-5046. PubMed ID: 34497433
[TBL] [Abstract][Full Text] [Related]
26. Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease.
Li J; Butcher J; Mack D; Stintzi A
Inflamm Bowel Dis; 2015 Jan; 21(1):139-53. PubMed ID: 25248007
[TBL] [Abstract][Full Text] [Related]
27. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD.
Casén C; Vebø HC; Sekelja M; Hegge FT; Karlsson MK; Ciemniejewska E; Dzankovic S; Frøyland C; Nestestog R; Engstrand L; Munkholm P; Nielsen OH; Rogler G; Simrén M; Öhman L; Vatn MH; Rudi K
Aliment Pharmacol Ther; 2015 Jul; 42(1):71-83. PubMed ID: 25973666
[TBL] [Abstract][Full Text] [Related]
28. The fingerprint of the human gastrointestinal tract microbiota: a hypothesis of molecular mapping.
Tomasello G; Mazzola M; Jurjus A; Cappello F; Carini F; Damiani P; Gerges Geagea A; Zeenny MN; Leone A
J Biol Regul Homeost Agents; 2017; 31(1):245-249. PubMed ID: 28337900
[TBL] [Abstract][Full Text] [Related]
29. [The role of gut microbiota dysbiosis in the occurrence and development of inflammatory bowel disease and its prevention and control strategies].
Yang ZY; Li M
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Sep; 56(9):1175-1181. PubMed ID: 36207877
[TBL] [Abstract][Full Text] [Related]
30. Dysbiosis in intestinal inflammation: Cause or consequence.
Buttó LF; Haller D
Int J Med Microbiol; 2016 Aug; 306(5):302-309. PubMed ID: 27012594
[TBL] [Abstract][Full Text] [Related]
31. Current Understanding of Dysbiosis in Disease in Human and Animal Models.
DeGruttola AK; Low D; Mizoguchi A; Mizoguchi E
Inflamm Bowel Dis; 2016 May; 22(5):1137-50. PubMed ID: 27070911
[TBL] [Abstract][Full Text] [Related]
32. Periodontal and inflammatory bowel diseases: Is there evidence of complex pathogenic interactions?
Lira-Junior R; Figueredo CM
World J Gastroenterol; 2016 Sep; 22(35):7963-72. PubMed ID: 27672291
[TBL] [Abstract][Full Text] [Related]
33. Modeling environmental risk factors of autism in mice induces IBD-related gut microbial dysbiosis and hyperserotonemia.
Lim JS; Lim MY; Choi Y; Ko G
Mol Brain; 2017 Apr; 10(1):14. PubMed ID: 28427452
[TBL] [Abstract][Full Text] [Related]
34. [Gut microbiota: Description, role and pathophysiologic implications].
Landman C; Quévrain E
Rev Med Interne; 2016 Jun; 37(6):418-23. PubMed ID: 26749318
[TBL] [Abstract][Full Text] [Related]
35. Understanding and Preventing the Global Increase of Inflammatory Bowel Disease.
Kaplan GG; Ng SC
Gastroenterology; 2017 Feb; 152(2):313-321.e2. PubMed ID: 27793607
[TBL] [Abstract][Full Text] [Related]
36. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.
Kang M; Martin A
Semin Immunol; 2017 Aug; 32():3-13. PubMed ID: 28465070
[TBL] [Abstract][Full Text] [Related]
37. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N
Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980
[TBL] [Abstract][Full Text] [Related]
38. Damage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets.
Nanini HF; Bernardazzi C; Castro F; de Souza HSP
World J Gastroenterol; 2018 Nov; 24(41):4622-4634. PubMed ID: 30416310
[TBL] [Abstract][Full Text] [Related]
39. Gut biofilm forming bacteria in inflammatory bowel disease.
Srivastava A; Gupta J; Kumar S; Kumar A
Microb Pathog; 2017 Nov; 112():5-14. PubMed ID: 28942174
[TBL] [Abstract][Full Text] [Related]
40. The microbiome in inflammatory bowel diseases: from pathogenesis to therapy.
Liu S; Zhao W; Lan P; Mou X
Protein Cell; 2021 May; 12(5):331-345. PubMed ID: 32601832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
